Effect of, OAT3, on the Renal Secretion of Cefotaxime

NCT00187655 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Focus Groups

Interventions

DRUG: Cefotaxime

Sponsor

University of California, San Francisco